Skip to main content
Springer logoLink to Springer
. 2020 Jul 15;22(8):41. doi: 10.1007/s11883-020-00869-1

Correction to: Lomitapide – a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia

Claudia Stefanutti 1,
PMCID: PMC7645553  PMID: 32671569

Correction to: Current Atherosclerosis Reports (2020)

https://doi.org/10.1007/s11883-020-00858-4

© The Author(s) 2020

Due to errors during galley proofing, the original version of this article has been corrected.

The following errors were corrected: page 4, paragraph 2, line 4, “week 126” is corrected to “week 246”; page 5, paragraph 1, line 2, “LDL” is corrected to “LDL-C”; page 5, paragraph 1, line 5, “absorbed” is corrected to “internalized”; page 6, paragraph 3, column 2, line 5, “from Spain” was corrected to “of an Hispanic female”; page 6, paragraph 5, line 13, “five” was corrected to “six”, and “two” was corrected to “three”; page 7, paragraph 2, line 4, “and no LA” was added after “20 mg/day”; page 7, paragraph 3, line 1, “a single” was corrected to “an”; Figure 1, “12-patient paediatric” should read “11-patient paediatric.” We also have p4 para 2 line 3 where 296 has been changed to 294, and same page, para 3, line 6 where awe have added ‘Risk’ to Risk Management Plan.

Footnotes

The online version of the original article can be found at 10.1007/s11883-020-00858-4

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Current Atherosclerosis Reports are provided here courtesy of Springer

RESOURCES